Cancer vaccinesBioNtech reports Car-T/mRNA booster study...BioNtech SE has reported preliminary Phase I/II results with BNT211-01 (NEO-PTC-01) and CarVAC at ESMO conference in Madrid more ➔
M&ARoche acquires Telavant Holdings to win TL...Analysts describe as sporting the €7.1bn for Roche AG’s acquisition of Roivant subsidiary Telavant Holdings. more ➔
AMRUK boosts AMR defenses with £30m PACE ini...In an effort to address the global health threat of antimicrobial resistance (AMR), Innovate UK, LifeArc, and Medicines Discovery Catapult have jointly launched the PACE (Pathways to Antimicrobial Clinical … more ➔
CPHI: Trends shaping pharma’s pathThis week CPHI 2023 will unite industry leaders, innovators, and start-ups to explore sustainable solutions, cutting-edge technologies, and collaborative partnerships. more ➔
FinancingXlife Sciences AG acquires 20% stake in 4D...In a significant financial milestone, Xlife Sciences AG invests CHF23.3m in 4D Lifetec AG. With the agreement signed today, Xlife Sciences is not only bringing in a direct cash investment, but also an … more ➔
CollaborationSpliceBio has made up a US $216m alliance...SpliceBio has licenced its intein technlogy to Roche’s gene therapy subsidiary Spark Therapeutics to develop a gene therapy targeting an undisclosed inherited retinal disease. more ➔
CollaborationAntiverse and GlobalBio Inc. extend collab...Antiverse Ltd and GlobalBio Inc. have extend their cancer antibody partnership to progress two PD-1 modulators to preclinial development more ➔
ADCSOTIO Biotech licenses ADCs from Lonza sub...Sotio hsd licenced Synaffix ADC platform for up to US$740m to develop up to three next generation bioconjugates. more ➔
World Health Summit opened in BerlinOn Sunday, the World Health Summit with more than 300 speakers officially kicked off in Berlin. The three day event focuses on climate change and health, pandemic prevention, and digital technologie … more ➔
financingSynerkine Pharma BV secures EUR 12.1m in S...Dutch Synerkine Pharma BV has closed a Seris A extension financincg at €12.1m to accelerate clinical development of its pain killer SK-01. more ➔
